Breakout Stocks: How to trade Divi’s Laboratories, Ipca Laboratories and Glenmark Pharma on Monday?
Written by
, ETMarkets.com|
1/7
Market Summary
ANI

2/7
Sectoral Summary
iStock

3/7
Breakout Stocks
ETMarkets.com

4/7
Analyst Call
Analyst: Drumil Vithlani, Technical Analyst, Bonanza
ETMarkets.com

5/7
Divi's Laboratories: Buy on Dips
Despite sluggish performance in the broader indices, the stock reached a fresh record high of 6,159.85, highlighting its strong momentum.
The price structure reveals a rounding formation breakout, followed by a healthy three-week correction, and now a sharp bullish candle, signaling a continuation of the uptrend.
In summary, the trend for DIVISLAB remains bullish. Investors can consider using dips towards 5,865 as a buying opportunity
ETMarkets.com

6/7
Ipca Laboratories Ltd: Buy
The volume increase supports the price action, indicating buyers are keen to buy the security at the current market price. On the average front the price is trading above its 50 and 200 EMA indicating an uptrend.
On the directional front DI+ is trading above DI- indicating an uptrend whereas ADX trading above DI- indicates strength in the move.
ETMarkets.com

7/7
Glenmark Pharma: Buy
The stock has recently broken out from a rounding bottom formation on the weekly chart, with the latest candlestick displaying a long-bodied green candle, signaling potential upside momentum.
This week's formation of a bullish Marubozu pattern further supports the likelihood of continued upward movement.
Additionally, the Relative Strength Index (RSI) is positioned above its moving average and is trending upward, indicating sustained positive momentum in the near term
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
ETMarkets.com